Nufarm (NUF) investor relations material

Strategy and business direction

• Portfolio sharpened to focus on crops and segments with clear competitive advantage, reducing investment in commodity products lacking differentiation.

• Innovation accessed through partnerships with start-ups, institutions, and universities, lowering technical and commercial risk.

• Investment prioritized in high-returning seeds, expansion of carinata with bp, and a measured approach to omega-3.

• Emphasis on quality and differentiation over breadth, aligning cost and capital base to focused markets.

• Strategy aims for higher, more durable returns through disciplined capital allocation and selective market participation.

Financial performance and guidance

• FY26 EBITDA guidance set at $370–380m, representing approximately 25% growth year-over-year.

• Leverage targeted at approximately 2.0x, down from 2.7x, with positive free cash flow expected.

• $50m cost savings program on track, with full benefit expected by FY28 and majority of savings from cost of goods sold.

• Capital expenditure capped under $200m for FY26–FY28, with a focus on efficient allocation and returns above WACC.

• Free cash flow improved by $193m year-over-year, with asset optimization and portfolio actions underway.

Crop protection and innovation

• Focused investment in differentiated resistance management, biological solutions, and specialty crops.

• Three core crop systems prioritized: cereals, trees/nuts/vines, and soybean, representing 46% of the $80b global market.

• Near-term pipeline includes products with a total addressable market of ~$8b, with launches planned through 2033.

• Regional strategies tailored to strengths: growth in APAC, profitable growth in Europe, and improved returns in North America.

• Partnerships drive innovation, enabling capital-efficient growth and access to differentiated products.